NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D’Amico, Thomas J. Dilling, Michael Dobelbower, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Rudy P Lackner, Michael Lanuti, Ticiana A. Leal, Rogerio Lilenbaum, Jules Lin, Billy W. LooRenato Martins, Gregory A. Otterson, Sandip P. Patel, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt Tauer, Stephen C. Yang, Kristina Gregory, Miranda Hughes

Research output: Contribution to journalReview article

57 Citations (Scopus)

Abstract

The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

Original languageEnglish (US)
Pages (from-to)807-821
Number of pages15
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number7
DOIs
StatePublished - Jul 1 2018

Fingerprint

Non-Small Cell Lung Carcinoma
Guidelines
Immunotherapy
Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines . / Ettinger, David S.; Aisner, Dara L.; Wood, Douglas E.; Akerley, Wallace; Bauman, Jessica; Chang, Joe Y.; Chirieac, Lucian R.; D’Amico, Thomas A.; Dilling, Thomas J.; Dobelbower, Michael; Govindan, Ramaswamy; Gubens, Matthew A.; Hennon, Mark; Horn, Leora; Lackner, Rudy P; Lanuti, Michael; Leal, Ticiana A.; Lilenbaum, Rogerio; Lin, Jules; Loo, Billy W.; Martins, Renato; Otterson, Gregory A.; Patel, Sandip P.; Reckamp, Karen; Riely, Gregory J.; Schild, Steven E.; Shapiro, Theresa A.; Stevenson, James; Swanson, Scott J.; Tauer, Kurt; Yang, Stephen C.; Gregory, Kristina; Hughes, Miranda.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 16, No. 7, 01.07.2018, p. 807-821.

Research output: Contribution to journalReview article

Ettinger, DS, Aisner, DL, Wood, DE, Akerley, W, Bauman, J, Chang, JY, Chirieac, LR, D’Amico, TA, Dilling, TJ, Dobelbower, M, Govindan, R, Gubens, MA, Hennon, M, Horn, L, Lackner, RP, Lanuti, M, Leal, TA, Lilenbaum, R, Lin, J, Loo, BW, Martins, R, Otterson, GA, Patel, SP, Reckamp, K, Riely, GJ, Schild, SE, Shapiro, TA, Stevenson, J, Swanson, SJ, Tauer, K, Yang, SC, Gregory, K & Hughes, M 2018, ' NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines ', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 7, pp. 807-821. https://doi.org/10.6004/jnccn.2018.0062
Ettinger, David S. ; Aisner, Dara L. ; Wood, Douglas E. ; Akerley, Wallace ; Bauman, Jessica ; Chang, Joe Y. ; Chirieac, Lucian R. ; D’Amico, Thomas A. ; Dilling, Thomas J. ; Dobelbower, Michael ; Govindan, Ramaswamy ; Gubens, Matthew A. ; Hennon, Mark ; Horn, Leora ; Lackner, Rudy P ; Lanuti, Michael ; Leal, Ticiana A. ; Lilenbaum, Rogerio ; Lin, Jules ; Loo, Billy W. ; Martins, Renato ; Otterson, Gregory A. ; Patel, Sandip P. ; Reckamp, Karen ; Riely, Gregory J. ; Schild, Steven E. ; Shapiro, Theresa A. ; Stevenson, James ; Swanson, Scott J. ; Tauer, Kurt ; Yang, Stephen C. ; Gregory, Kristina ; Hughes, Miranda. / NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines In: JNCCN Journal of the National Comprehensive Cancer Network. 2018 ; Vol. 16, No. 7. pp. 807-821.
@article{8399a26680514931b4230c8382a04ca0,
title = "NCCN guidelines {\circledR} insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines",
abstract = "The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.",
author = "Ettinger, {David S.} and Aisner, {Dara L.} and Wood, {Douglas E.} and Wallace Akerley and Jessica Bauman and Chang, {Joe Y.} and Chirieac, {Lucian R.} and D’Amico, {Thomas A.} and Dilling, {Thomas J.} and Michael Dobelbower and Ramaswamy Govindan and Gubens, {Matthew A.} and Mark Hennon and Leora Horn and Lackner, {Rudy P} and Michael Lanuti and Leal, {Ticiana A.} and Rogerio Lilenbaum and Jules Lin and Loo, {Billy W.} and Renato Martins and Otterson, {Gregory A.} and Patel, {Sandip P.} and Karen Reckamp and Riely, {Gregory J.} and Schild, {Steven E.} and Shapiro, {Theresa A.} and James Stevenson and Swanson, {Scott J.} and Kurt Tauer and Yang, {Stephen C.} and Kristina Gregory and Miranda Hughes",
year = "2018",
month = "7",
day = "1",
doi = "10.6004/jnccn.2018.0062",
language = "English (US)",
volume = "16",
pages = "807--821",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "7",

}

TY - JOUR

T1 - NCCN guidelines ® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelines

AU - Ettinger, David S.

AU - Aisner, Dara L.

AU - Wood, Douglas E.

AU - Akerley, Wallace

AU - Bauman, Jessica

AU - Chang, Joe Y.

AU - Chirieac, Lucian R.

AU - D’Amico, Thomas A.

AU - Dilling, Thomas J.

AU - Dobelbower, Michael

AU - Govindan, Ramaswamy

AU - Gubens, Matthew A.

AU - Hennon, Mark

AU - Horn, Leora

AU - Lackner, Rudy P

AU - Lanuti, Michael

AU - Leal, Ticiana A.

AU - Lilenbaum, Rogerio

AU - Lin, Jules

AU - Loo, Billy W.

AU - Martins, Renato

AU - Otterson, Gregory A.

AU - Patel, Sandip P.

AU - Reckamp, Karen

AU - Riely, Gregory J.

AU - Schild, Steven E.

AU - Shapiro, Theresa A.

AU - Stevenson, James

AU - Swanson, Scott J.

AU - Tauer, Kurt

AU - Yang, Stephen C.

AU - Gregory, Kristina

AU - Hughes, Miranda

PY - 2018/7/1

Y1 - 2018/7/1

N2 - The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

AB - The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the targeted therapy and immunotherapy sections in the NCCN Guidelines. For the 2018 update, a new section on biomarkers was added.

UR - http://www.scopus.com/inward/record.url?scp=85049839389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049839389&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0062

DO - 10.6004/jnccn.2018.0062

M3 - Review article

C2 - 30006423

AN - SCOPUS:85049839389

VL - 16

SP - 807

EP - 821

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 7

ER -